Umar, T.P. et al. 2020. Urokinase Plasminogen Activator Receptor (uPAR) Targeted Therapy with Switchable Chimeric Antigen Receptor T-Cell (sCAR T-Cell) Potential as Pancreatic Cancer Immunotherapy Agent. International Journal of Human and Health Sciences (IJHHS). 5, 2 (Oct. 2020), 171–176. DOI:https://doi.org/10.31344/ijhhs.v5i2.255.